467 related articles for article (PubMed ID: 23766428)
41. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm.
Hung JJ; Jeng WJ; Hsu WH; Lin SF; Hsieh CC; Huang BS; Huang MH; Liu JS; Chou TY; Wu YC
Eur Respir J; 2010 Dec; 36(6):1355-61. PubMed ID: 20516056
[TBL] [Abstract][Full Text] [Related]
42. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
[TBL] [Abstract][Full Text] [Related]
43. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
44. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
46. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
47. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
[TBL] [Abstract][Full Text] [Related]
48. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
49. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
[TBL] [Abstract][Full Text] [Related]
50. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
51. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.
Massabeau C; Filleron T; Wakil G; Rouquette I; Bachaud JM; Leguellec S; Delisle MB; Toulas C; Mazieres J; Cohen-Jonathan Moyal E
Clin Lung Cancer; 2012 Jan; 13(1):59-67. PubMed ID: 21856239
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
53. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
[TBL] [Abstract][Full Text] [Related]
55. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
56. [Risk factors of recurrence in resected stage I non-small cell lung cancer].
Kita H; Koshiishi Y; Masui K; Fujita A; Ootsuka K; Furuyashiki G; Nakazato Y; Takei H; Goya T
Kyobu Geka; 2007 Sep; 60(10):883-7. PubMed ID: 17877005
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
58. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
Gao YS; Xing XZ; Shao K; Feng XL; He J
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
[TBL] [Abstract][Full Text] [Related]
59. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
[TBL] [Abstract][Full Text] [Related]
60. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
